SCHEMBL4456843

SCHEMBL4456843

C[SiH](C)[Zr](Cl)(Cl)(CCCC1C=Cc2ccccc21)CC1C=Cc2ccccc21

nearest known ligand 0.37

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
HTR6 P50406 1/20 0.37
SIGMAR1 Q99720 2/20 0.32
KDM4E B2RXH2 2/20 0.32
LMNA P02545 1/20 0.32
TP53 P04637 1/20 0.32
CHRM2 P08172 1/20 0.32
CYP3A4 P08684 1/20 0.32
CYP2D6 P10635 1/20 0.32
CHRM1 P11229 1/20 0.32
DRD2 P14416 1/20 0.32
ADRA2B P18089 1/20 0.32
ADRA2C P18825 1/20 0.32
NFKB1 P19838 1/20 0.32
CHRM3 P20309 1/20 0.32
SLC6A2 P23975 1/20 0.32
HTR2A P28223 1/20 0.32
HTR2C P28335 1/20 0.32
ADRA1A P35348 1/20 0.32
HRH1 P35367 1/20 0.32
DRD3 P35462 1/20 0.32

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL6062261 0.93 HTR6 (0.39) HTR6SIGMAR1KDM4ELMNATP53
SCHEMBL4464597 0.91 HTR6 (0.38) HTR6SIGMAR1KDM4ELMNATP53
SCHEMBL4480045 0.87 HTR6 (0.43) HTR6SIGMAR1KDM4ELMNATP53
SCHEMBL4460058 0.81 HTR6 (0.36) HTR6SIGMAR1KDM4ELMNATP53
SCHEMBL6061548 0.80 HTR6 (0.38) HTR6SIGMAR1KDM4ELMNATP53
SCHEMBL6061594 0.78 HTR6 (0.40) HTR6SIGMAR1KDM4ELMNATP53
SCHEMBL6061751 0.76 HTR6 (0.38) HTR6SIGMAR1KDM4ELMNATP53
SCHEMBL6673091 0.74 HTR6 (0.53) HTR6SIGMAR1KDM4ELMNATP53
SCHEMBL1949777 0.74 HTR6 (0.53) HTR6SIGMAR1KDM4ELMNATP53
SCHEMBL4471513 0.74 HTR6 (0.35) HTR6SIGMAR1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 5 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20060142147-A1 Catalysts compositions for the polymerization and copolymerization of alpha-olefins REPSOL QUIMICA, S.A. (ES) 2006-06-29 US claimed
EP-1671983-A1 Catalysts compositions for the polymerization and copolymerization of alpha-olefins REPSOL QUIMICA S.A. (ES) 2006-06-21 EP claimed
EP-1671983-B1 Catalysts compositions for the polymerization and copolymerization of alpha-olefins REPSOL QUIMICA SA (ES) 2009-02-25 EP disclosed
US-20060142147-A1 Catalysts compositions for the polymerization and copolymerization of alpha-olefins REPSOL QUIMICA, S.A. (ES) 2006-06-29 US disclosed
EP-1671983-A1 Catalysts compositions for the polymerization and copolymerization of alpha-olefins REPSOL QUIMICA S.A. (ES) 2006-06-21 EP disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20060142147-A1 Catalysts compositions for the polymerization and copolymerization of alpha-olefins B2M, OPRM1, POLM HTR6 1387/4885SIGMAR1 704/4885KDM4E 4626/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.